PureTech Health
PRTC
PRTC was delisted on the 20th of May, 2026.
4 hedge funds and large institutions have $6.9M invested in PureTech Health in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and closing their positions.
265% more capital invested
Capital invested by funds: $1.89M → $6.9M (+$5.01M)
100% more funds holding
Funds holding: 2 → 4 (+2)
0.47% more ownership
Funds ownership: 0.02% → 0.5% (+0.47%)
Top Buyers
| 1 |
AIC
AWM Investment Company
New York
|
+$38.7M |
| 2 |
Jane Street
New York
|
+$248K |
| 3 |
OMC
Old Mission Capital
Chicago,
Illinois
|
+$193K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
AIC
1
AWM Investment Company
New York
| $6.42M | +$38.7M | +1,300,000 | +1,857% |
|
|
2
Jane Street
New York
| $269K | +$248K | +8,343 | New |
|
|
OMC
3
Old Mission Capital
Chicago,
Illinois
| $207K | +$193K | +6,483 | New |
|
4
UBS Group
Zurich,
Switzerland
| $638 | – | – | – |
|
PRTC Hedge Fund Activity: Q4 2022 in Review
4 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in PureTech Health (PRTC) for Q4 2022, worth a combined $6.9M — up 265% from $1.89M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PRTC positions and 0 closed out — a net gain of 2 holders — while 1 added to existing stakes and 0 trimmed.
The largest buyer was AWM Investment Company, adding an estimated $38.7M.
- 4 institutional investors held PureTech Health (PRTC) as of Q4 2022, up from 2 in Q3 2022.
- Funds reported $6.9M of PureTech Health stock for Q4 2022, up 265% quarter-over-quarter.
- 2 funds opened new PureTech Health positions in Q4 2022 and 0 closed out, a net change of +2 holders.
- The largest PureTech Health buyer in Q4 2022 was AWM Investment Company, an estimated $38.7M added.
Based on aggregated 13F filings for Q4 2022.